Stay updated on Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.

Latest updates to the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page
- Check8 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check44 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical trial for unresectable pancreatic cancer and the update of the revision number from v2.14.4 to v2.15.0.SummaryDifference13%
- Check51 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check95 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check109 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.